Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial

Giuseppe Biondi-Zoccai, Sebastiano Sciarretta, Christopher Bullen, Cristina Nocella, Francesco Violi, Lorenzo Loffredo, Pasquale Pignatelli, Ludovica Perri, Mariangela Peruzzi, Antonino G M Marullo, Elena De Falco, Isotta Chimenti, Vittoria Cammisotto, Valentina Valenti, Flaminia Coluzzi, Elena Cavarretta, Albino Carrizzo, Francesco Prati, Roberto Carnevale, Giacomo Frati, Giuseppe Biondi-Zoccai, Sebastiano Sciarretta, Christopher Bullen, Cristina Nocella, Francesco Violi, Lorenzo Loffredo, Pasquale Pignatelli, Ludovica Perri, Mariangela Peruzzi, Antonino G M Marullo, Elena De Falco, Isotta Chimenti, Vittoria Cammisotto, Valentina Valenti, Flaminia Coluzzi, Elena Cavarretta, Albino Carrizzo, Francesco Prati, Roberto Carnevale, Giacomo Frati

Abstract

Background Little clinical research on new-generation heat-not-burn cigarettes ( HNBC ) in comparison with electronic vaping cigarettes ( EVC ) and traditional tobacco combustion cigarettes ( TC ) has been reported. We aimed to appraise the acute effects of single use of HNBC , EVC, and TC in healthy smokers. Methods and Results This was an independent, cross-over, randomized trial in 20 TC smokers, with allocation to different cycles of HNBC , EVC , and TC . All participants used all types of products, with an intercycle washout of 1 week. End points were oxidative stress, antioxidant reserve, platelet activation, flow-mediated dilation, blood pressure, and satisfaction scores. Single use of any product led to an adverse impact on oxidative stress, antioxidant reserve, platelet function, flow-mediated dilation, and blood pressure. HNBC had less impact than EVC and TC on soluble Nox2-derived peptide (respectively, P=0.004 and 0.001), 8-iso-prostaglandin F2α- III ( P=0.004 and <0.001), and vitamin E ( P=0.018 and 0.044). HNBC and EVC were equally less impactful than TCs on flow-mediated dilation ( P=0.872 for HNBC versus EVC ), H2O2 ( P=0.522), H2O2 breakdown activity ( P=0.091), soluble CD 40 ligand ( P=0.849), and soluble P-selectin ( P=0.821). The effect of HNBC and, to a lesser extent EVC , on blood pressure was less evident than that of TC , whereas HNBC appeared more satisfying than EVC (all P<0.05). Conclusions Acute effects of HNBC , EVC, and TC are different on several oxidative stress, antioxidant reserve, platelet function, cardiovascular, and satisfaction dimensions, with TCs showing the most detrimental changes in clinically relevant features. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 03301129.

Trial registration: ClinicalTrials.gov NCT03301129.

Keywords: flow‐induced dilation; oxidative stress; platelet; platelet aggregation; smoking.

Figures

Figure 1
Figure 1
Impact of using electronic cigarette (EVC), traditional tobacco cigarette (TC), and heat‐not‐burn cigarette (HNBC) on blood levels of soluble Nox2‐derived peptide. Box plots represent median, first quartile, third quartile, fifth percentile, 95th percentile, and outliers.
Figure 2
Figure 2
Impact of using electronic cigarette (EVC), traditional tobacco cigarette (TC), and heat‐not‐burn cigarette (HNBC) on flow‐mediated dilation (FMD). Box plots represent median, first quartile, third quartile, fifth percentile, 95th percentile, and outliers.

References

    1. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 2008;5:811–815.
    1. Stallones RA. The association between tobacco smoking and coronary heart disease. Int J Epidemiol. 2015;44:735–743.
    1. Carnevale R, Loffredo L, Pignatelli P, Nocella C, Bartimoccia S, Di Santo S, Martino F, Catasca E, Perri L, Violi F. Dark chocolate inhibits platelet isoprostanes via NOX2 down‐regulation in smokers. J Thromb Haemost. 2012;10:125–132.
    1. Loffredo L, Carnevale R, Perri L, Catasca E, Augelletti T, Cangemi R, Albanese F, Piccheri C, Nocella C, Pignatelli P, Violi F. NOX2‐mediated arterial dysfunction in smokers: acute effect of dark chocolate. Heart. 2011;97:1776–1781.
    1. Hahn J, Monakhova YB, Hengen J, Kohl‐Himmelseher M, Schüssler J, Hahn H, Kuballa T, Lachenmeier DW. Electronic cigarettes: overview of chemical composition and exposure estimation. Tob Induc Dis. 2014;12:23.
    1. Tabuchi T, Kiyohara K, Hoshino T, Bekki K, Inaba Y, Kunugita N. Awareness and use of electronic cigarettes and heat‐not‐burn tobacco products in Japan. Addiction. 2016;111:706–713.
    1. Chen J, Bullen C, Dirks K. A comparative health risk assessment of electronic cigarettes and conventional cigarettes. Int J Environ Res Public Health. 2017;14:E382.
    1. Dinakar C, O'Connor GT. The health effects of electronic cigarettes. N Engl J Med. 2016;375:2608–2609.
    1. National Academies of Sciences, Engineering, and Medicine . Public Health Consequences of E‐Cigarettes. Washington, DC: The National Academies Press; 2018. DOI: 10.17226/24952. . Accessed December 13, 2018.
    1. Schaller JP, Keller D, Poget L, Pratte P, Kaelin E, McHugh D, Cudazzo G, Smart D, Tricker AR, Gautier L, Yerly M, Reis Pires R, Le Bouhellec S, Ghosh D, Hofer I, Garcia E, Vanscheeuwijck P, Maeder S. Evaluation of the Tobacco Heating System 2.2, part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 2016;81(Suppl 2):S27–S47.
    1. Auer R, Concha‐Lozano N, Jacot‐Sadowski I, Cornuz J, Berthet A. Heat‐not‐burn tobacco cigarettes: smoke by any other name. JAMA Intern Med. 2017;177:1050–1052.
    1. Carnevale R, Sciarretta S, Violi F, Nocella C, Loffredo L, Perri L, Peruzzi M, Marullo AG, De Falco E, Chimenti I, Valenti V, Biondi‐Zoccai G, Frati G. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150:606–612.
    1. Nocella C, Biondi‐Zoccai G, Sciarretta S, Peruzzi M, Pagano F, Loffredo L, Pignatelli P, Bullen C, Frati G, Carnevale R. Impact of tobacco versus electronic cigarette smoking on platelet function. Am J Cardiol. 2018;122:1477–1481.
    1. Hom S, Chen L, Wang T, Ghebrehiwet B, Yin W, Rubenstein DA. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets. 2016;27:694–702.
    1. Nabavizadeh P, Liu J, Havel CM, Ibrahim S, Derakhshandeh R, Jacob Iii P, Springer ML. Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob Control. 2018;27:s13–s19.
    1. Shiffman S, Terhorst L. Intermittent and daily smokers’ subjective responses to smoking. Psychopharmacology. 2017;234:2911–2917.
    1. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard‐Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force . Guidelines for the ultrasound assessment of endothelial‐dependent flow‐mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265.
    1. Loffredo L, Marcoccia A, Pignatelli P, Andreozzi P, Borgia MC, Cangemi R, Chiarotti F, Violi F. Oxidative‐stress‐mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J. 2007;28:608–612.
    1. Carnevale R, Silvestri R, Loffredo L, Novo M, Cammisotto V, Castellani V, Bartimoccia S, Nocella C, Violi F. Oleuropein, a component of extra virgin olive oil, lowers post‐prandial glycaemia in healthy subjects. Br J Clin Pharmacol. 2018;84:1566–1574.
    1. Aust O, Sies H, Stahl W, Polidori MC. Analysis of lipophilic antioxidants in human serum and tissues: tocopherols and carotenoids. J Chromatogr A. 2001;936:83–93.
    1. Traber MG, Jialal I. Measurement of lipid‐soluble vitamins—further adjustment needed? Lancet. 2000;355:2013–2014.
    1. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204.
    1. Bernhard D, Wang XL. Smoking, oxidative stress and cardiovascular diseases—do anti‐oxidative therapies fail? Curr Med Chem. 2007;14:1703–1712.
    1. Fuentes E, Gibbins JM, Holbrook LM, Palomo I. NADPH oxidase 2 (NOX2): a key target of oxidative stress‐mediated platelet activation and thrombosis. Trends Cardiovasc Med. 2018;28:429–434.
    1. Loffredo L, Martino F, Carnevale R, Pignatelli P, Catasca E, Perri L, Calabrese CM, Palumbo MM, Baratta F, Del Ben M, Angelico F, Violi F. Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction. J Pediatr. 2012;161:1004–1009.
    1. Del Ben M, Polimeni L, Carnevale R, Bartimoccia S, Nocella C, Baratta F, Loffredo L, Pignatelli P, Violi F, Angelico F. NOX2‐generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non‐alcoholic fatty liver disease. BMC Gastroenterol. 2014;14:81.
    1. Angelico F, Loffredo L, Pignatelli P, Augelletti T, Carnevale R, Pacella A, Albanese F, Mancini I, Di Santo S, Del Ben M, Violi F. Weight loss is associated with improved endothelial dysfunction via NOX2‐generated oxidative stress down‐regulation in patients with the metabolic syndrome. Intern Emerg Med. 2012;7:219–227.
    1. Loffredo L, Carnevale R, Cangemi R, Angelico F, Augelletti T, Di Santo S, Calabrese CM, Della Volpe L, Pignatelli P, Perri L, Basili S, Violi F. NOX2 up‐regulation is associated with artery dysfunction in patients with peripheral artery disease. Int J Cardiol. 2013;165:184–192.
    1. Pignatelli P, Pastori D, Carnevale R, Farcomeni A, Cangemi R, Nocella C, Bartimoccia S, Vicario T, Saliola M, Lip GY, Violi F. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. Thromb Haemost. 2015;113:617–624.
    1. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4:181–189.
    1. Violi F, Sanguigni V, Carnevale R, Plebani A, Rossi P, Finocchi A, Pignata C, De Mattia D, Martire B, Pietrogrande MC, Martino S, Gambineri E, Soresina AR, Pignatelli P, Martino F, Basili S, Loffredo L. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation. 2009;120:1616–1622.
    1. Carnevale R, Nocella C, Pignatelli P, Bartimoccia S, Stefanini L, Basili S, Novo M, D'Amico A, Cammisotto V, Pastori D, Violi F. Blood hydrogen peroxide break‐down activity in healthy subjects and in patients at risk of cardiovascular events. Atherosclerosis. 2018;274:29–34.
    1. Vardi M, Levy NS, Levy AP. Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection. J Lipid Res. 2013;54:2307–2314.
    1. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370:60–68.
    1. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska‐Czapla M, Rosik‐Dulewska C, Havel C, Jacob P III, Benowitz N. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133–139.
    1. Moheimani RS, Bhetraratana M, Peters KM, Yang BK, Yin F, Gornbein J, Araujo JA, Middlekauff HR. Sympathomimetic effects of acute E‐cigarette use: role of nicotine and non‐nicotine constituents. J Am Heart Assoc. 2017;6:e006579 DOI: 10.1161/JAHA.117.006579.
    1. Moheimani RS, Bhetraratana M, Yin F, Peters KM, Gornbein J, Araujo JA, Middlekauff HR. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2:278–284.
    1. Glasser AM, Collins L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC. Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med. 2017;52:e33–e66.
    1. Liu X, Lugo A, Spizzichino L, Tabuchi T, Pacifici R, Gallus S. Heat‐not‐burn tobacco products: concerns from the Italian experience. Tob Control. 2019;28:113–114.
    1. Davis B, Williams M, Talbot P. iQOS: evidence of pyrolysis and release of a toxicant from plastic. Tob Control. 2019;28:34–41.
    1. Avdalovic MV, Murin S. POINT: does the risk of electronic cigarettes exceed potential benefits? Yes. Chest. 2015;148:580–582.
    1. Middlekauff HR. COUNTERPOINT: does the risk of electronic cigarettes exceed potential benefits? No. Chest. 2015;148:582–584.
    1. Fairchild AL, Lee JS, Bayer R, Curran J. E‐cigarettes and the harm‐reduction continuum. N Engl J Med. 2018;378:216–219.
    1. Mastrangeli S, Carnevale R, Cavarretta E, Sciarretta S, Peruzzi M, Marullo AGM, De Falco E, Chimenti I, Valenti V, Bullen C, Roever L, Frati G, Biondi‐Zoccai G. Predictors of oxidative stress and vascular function in an experimental study of tobacco versus electronic cigarettes: a post‐hoc analysis of the SUR‐VAPES 1 (Sapienza University of Rome‐Vascular Assessment of Proatherosclerotic Effects of Smoking) Study. Tob Induc Dis. 2018;16:11.
    1. Calvieri C, Tanzilli G, Bartimoccia S, Cangemi R, Arrivi A, Dominici M, Cammisotto V, Viceconte N, Mangieri E, Frati G, Violi F. Interplay between oxidative stress and platelet activation in coronary thrombus of STEMI patients. Antioxidants (Basel). 2018;7:E83.
    1. Carnevale R, Loffredo L, Nocella C, Bartimoccia S, Bucci T, De Falco E, Peruzzi M, Chimenti I, Biondi‐Zoccai G, Pignatelli P, Violi F, Frati G. Epicatechin and catechin modulate endothelial activation induced by platelets of patients with peripheral artery disease. Oxid Med Cell Longev. 2014;2014:691015.
    1. Biondi‐Zoccai G, Peruzzi M, Frati G. E‐cigarettes, incentives, and drugs for smoking cessation. N Engl J Med. 2018;379:991–992.
    1. Auf R, Trepka MJ, Selim M, Ben Taleb Z, De La Rosa M, Cano MÁ. E‐cigarette marketing exposure and combustible tobacco use among adolescents in the United States. Addict Behav. 2018;78:74–79.
    1. King AC, Smith LJ, McNamara PJ, Cao D. Second generation electronic nicotine delivery system vape pen exposure generalizes as a smoking cue. Nicotine Tob Res. 2018;20:246–252.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa